HFM Investment Advisors’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$164K Buy
137
+13
+10% +$13.3K 0.06% 29
2026
Q1
$115K Buy
124
+1
+0.8% +$1.01K 0.04% 37
2025
Q4
$132K Buy
123
+19
+18% +$18.2K 0.05% 34
2025
Q3
$79.7K Hold
104
0.03% 39
2025
Q2
$81.2K Buy
104
+5
+5% +$3.88K 0.04% 37
2025
Q1
$81K Buy
+99
New +$82.4K 0.04% 31

Other funds holding LLY

HFM Investment Advisors's LLY Position: Q2 2026 in Review

HFM Investment Advisors increased its Eli Lilly (LLY) stake by 10% in Q2 2026, buying an estimated $13.3K and bringing the position to 137 shares worth $164K. The position accounts for 0.06% of the portfolio, ranked #29.

HFM Investment Advisors first reported a position in LLY in Q1 2025 and has held it in 6 quarters since. 4,624 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • HFM Investment Advisors held 137 shares of Eli Lilly worth $164K as of Q2 2026.
  • HFM Investment Advisors bought 13 Eli Lilly shares in Q2 2026, an estimated $13.3K.
  • Eli Lilly made up 0.06% of HFM Investment Advisors's portfolio in Q2 2026, its #29 holding.
  • HFM Investment Advisors first reported a position in Eli Lilly in Q1 2025 and has held it in 6 quarters since.
  • 4,624 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on HFM Investment Advisors's 13F filing for Q2 2026, filed 4 Aug 2026.